PreprintAll rights reservedbioRxiv
Nuclear Cathepsin L Remodels the Replication Machinery to Create a Therapeutic Vulnerability in Ovarian Cancer
- 1Mayo Clinic
Related
- The Cathepsin Network: Multifaceted Regulators and Emerging Therapeutic Targets in Breast Cancer.
- SDHB deficiency silences ABCB1 expression and confers therapeutic vulnerability across multiple cancer types
- SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma
- Choline Kinase Alpha Inhibition is a Mutation Agnostic Therapeutic Vulnerability in Clonal Hematopoiesis
- DEGS1-mTORC1-driven lipid metabolic reprogramming fuels rhabdomyosarcoma progression and unveils a therapeutic vulnerability
BibTeX
@misc{thirusangu2026nuclear,
title = {{Nuclear Cathepsin L Remodels the Replication Machinery to Create a Therapeutic Vulnerability in Ovarian Cancer}},
author = {P. Thirusangu and L. Jin and S. Rao and K. Balakrishnan and X. Hou and J. L. VanBlaricom and S.-H. Lee and A. L. Oberg and J. Weroha and S. H. Kaufmann and J. N. Bakkum-Gamez and V. Shridhar},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.02.748933},
url = {https://www.biorxiv.org/content/10.64898/2026.09.02.748933v1},
}
RIS
TY - UNPB
TI - Nuclear Cathepsin L Remodels the Replication Machinery to Create a Therapeutic Vulnerability in Ovarian Cancer
AU - P. Thirusangu
AU - L. Jin
AU - S. Rao
AU - K. Balakrishnan
AU - X. Hou
AU - J. L. VanBlaricom
AU - S.-H. Lee
AU - A. L. Oberg
AU - J. Weroha
AU - S. H. Kaufmann
AU - J. N. Bakkum-Gamez
AU - V. Shridhar
PY - 2026
DA - 2026/09/02
PB - bioRxiv
DO - 10.64898/2026.09.02.748933
UR - https://www.biorxiv.org/content/10.64898/2026.09.02.748933v1
ER -